Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor-induced angioedema: A disproportionality analysis of the WHO pharmacovigilance database

被引：10
|
作者：
Lepelley, Marion [1 ]
Khouri, Charles [1 ]
Lacroix, Clemence [2 ]
Bouillet, Laurence [3 ]
机构：
[1] CHU Grenoble Alpes, Ctr Reg Pharmacovigilance, Grenoble, France
[2] AP HP, Ctr Reg Pharmacovigilance, Marseille, France
[3] CHU Grenoble Alpes, Med Interne, Ctr Natl Reference Angioedemes Bradykin, Grenoble, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2020年 / 8卷 / 07期
关键词：
RISK;
D O I：
10.1016/j.jaip.2020.03.015
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2406 / +
页数：4
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Wilkerson, R. Gentry
    Winters, Michael E.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2022, 40 (01) : 79 - 98
  • [2] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Theyab, Abduljabar A.
    Lee, David S.
    Khachemoune, Amor
    CUTIS, 2013, 91 (01): : 30 - 35
  • [3] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Wilkerson, R. Gentry
    Winters, Michael E.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (03) : 513 - 532
  • [4] Angiotensin-converting Enzyme Inhibitor-induced Angioedema
    Bezalel, Shira
    Mahlab-Guri, Keren
    Asher, Ilan
    Werner, Ben
    Sthoeger, Zev Moshe
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (02): : 120 - 125
  • [5] Bradykinin-mediated angioedema associated with combination of angiotensin-converting enzyme and dipeptidyl peptidase iv inhibitors: a disproportionality analysis from the who database
    Lepelley, M.
    Khouri, C.
    Mallaret, M.
    Bouillet, L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S40 - S40
  • [6] Bradykinin-mediated angioedema associated with combination of angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: a disproportionality analysis from the WHO database
    Lepelley, M.
    Khouri, C.
    Geneletti, L.
    Mallaret, M.
    Bouillet, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 9 - 9
  • [7] Bradykinin-mediated angioedema associated with combination of angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: a disproportionality analysis from the WHO database
    Lepelley, M.
    Khouri, C.
    Geneletti, L.
    Mallaret, M.
    Bouillet, L.
    ALLERGY, 2018, 73 : 567 - 567
  • [8] Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema
    Pall, Amalie Hartvig
    Rasmussen, Eva Rye
    Wadelius, Mia
    PHARMACOGENOMICS, 2021, 22 (06)
  • [9] Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema
    Liau, Yusmiati
    Chua, Ignatius
    Kennedy, Martin A.
    Maggo, Simran
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (02): : 142 - 154
  • [10] Management of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Al-Khudari, Samer
    Loochtan, Michael J.
    Peterson, Edward
    Yaremchuk, Kathleen L.
    LARYNGOSCOPE, 2011, 121 (11): : 2327 - 2334
12345